FDG positron emission tomography for evaluating esophageal cancer.
D054598:Blue Cross Blue Shield Insurance Plans; D004938:Esophageal Neoplasms / Q000000981:diagnostic imaging*; D006801:Humans; D019458:Insurance Coverage; D009367:Neoplasm Staging / Q000295:instrumentation / Q000379:methods; D012680:Sensitivity and Specificity; D013673:Technology Assessment, Biomedical; D014055:Tomography, Emission-Computed / Q000295:instrumentation / Q000379:methods; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome; D014481:United States; D014486:United States Food and Drug Administration